Alamar Biosciences, Inc.

US$28.05As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALMRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Medical Devices
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.949B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$36
29.41%
(64.62%)
Hold 5|4|12|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.67
0.64
0.66
0.68
45.48%
25.68%
17.54%
8.08%
Revenue$M
167.6
176.0
175.9
180.9
10.10%
10.56%
13.57%
12.42%
Peers (US$1.949B)
Cap (US$)
PE
1.853B
18.36x
1.952B
42.28x
Capital
TTM
5Y
10Y
Leveragex
0.838
0.131
0.131
EBIT/Intx
0.059
0.223
0.237
Own earn%
(14.21)
49.83
36.63
Sh yield%
20.74
31.65
30.20
Owners
Insiders/Inst%
2.91
80.40
Short interest%
4.55
SBC / revenue%
2.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
13–24
$1 testx
2.7
Incr. ROIC%
24